Moser Wealth Advisors LLC Sells 411 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Moser Wealth Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,630 shares of the exchange traded fund’s stock after selling 411 shares during the quarter. Moser Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $146,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the business. Verity Asset Management Inc. raised its position in shares of SPDR S&P Biotech ETF by 7.9% during the third quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock worth $1,258,000 after acquiring an additional 1,266 shares during the last quarter. Prime Capital Investment Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 52.6% in the 4th quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock worth $577,000 after purchasing an additional 2,228 shares during the period. Sequoia Financial Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $533,000. Y.D. More Investments Ltd increased its position in shares of SPDR S&P Biotech ETF by 5,500.0% during the fourth quarter. Y.D. More Investments Ltd now owns 5,600 shares of the exchange traded fund’s stock worth $500,000 after buying an additional 5,500 shares during the period. Finally, United Capital Management of KS Inc. raised its stake in SPDR S&P Biotech ETF by 1.8% during the fourth quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock worth $9,290,000 after buying an additional 1,831 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 0.1 %

XBI traded up $0.12 during trading on Thursday, reaching $89.23. 2,208,925 shares of the stock traded hands, compared to its average volume of 11,510,045. The stock’s 50-day moving average is $91.44 and its 200 day moving average is $85.80. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The stock has a market capitalization of $6.80 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.